Autoimmunity through cytokine-induced dendritic cell activation

Immunity

Volumn 20, Issue 5, 2004, Pages 539-550

  Banchereau, Jacques ^a   Pascual, Virginia ^a   Palucka, A Karolina ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; DNA; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 14; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIGEN PRESENTATION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL POPULATION; DENDRITIC CELL; DISEASE SEVERITY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; IMMUNOLOGICAL TOLERANCE; INTERFERON PRODUCTION; KERATINOCYTE; LYMPHOCYTOPENIA; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; MONOCYTE; MOUSE STRAIN; MULTIPLE SCLEROSIS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVIEW; RHEUMATOID ARTHRITIS; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THYMOCYTE; TUBERCULOSIS; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; INTERFERONS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442494120     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(04)00108-6     Document Type: Review

References (138)

1. Albert M.L., Pearce S.F., Francisco L.M., Sauter B., Roy P., Silverstein R.L., Bhardwaj N. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1998;1359-1368. a
2. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89. b
3. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., Harley J.B. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 349:2003;1526-1533
4. Arce E., Jackson D.G., Gill M.A., Bennett L.B., Banchereau J., Pascual V. Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 167:2001;2361-2369
5. Arpin C., Dechanet J., Van Kooten C., Merville P., Grouard G., Briere F., Banchereau J., Liu Y.J. Generation of memory B cells and plasma cells in vitro. Science. 268:1995;720-722
6. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F., et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:2001;1144-1150
7. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA. 100:2003;2610-2615
8. Balazs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 17:2002;341-352
9. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252
10. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811
11. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:2000;1453-1466
12. Bauer M., Redecke V., Ellwart J.W., Scherer B., Kremer J.P., Wagner H., Lipford G.B. Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells. J. Immunol. 166:2001;5000-5007
13. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., Kirchner T., Kalden J.R., Herrmann M. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46:2002;191-201
14. Bave U., Vallin H., Alm G.V., Ronnblom L. Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines. J. Autoimmun. 17:2001;71-80
15. Bellone M., Iezzi G., Rovere P., Galati G., Ronchetti A., Protti M.P., Davoust J., Rugarli C., Manfredi A.A. Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. 159:1997;5391-5399
16. Bennett L., Palucka A.K., Arce E., Cantrell V., Borvak J., Banchereau J., Pascual V. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:2003;711-723
17. Benoist C., Mathis D. Mast cells in autoimmune disease. Nature. 420:2002;875-878
18. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 298:2002;1025-1029
19. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense. function and regulation by innate cytokines Annu. Rev. Immunol. 17:1999;189-220
20. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 294:2001;1540-1543
21. Blomberg S., Eloranta M.L., Cederblad B., Nordlin K., Alm G.V., Ronnblom L. Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 10:2001;484-490
22. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:2003;253-257
23. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:2002;1627-1638
24. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., Brimnes M.K., Moltedo B., Moran T.M., Steinman R.M. In Vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:2004;815-824
25. Braun D., Geraldes P., Demengeot J. Type I interferon controls the onset and severity of autoimmune manifestations in lpr mice. J. Autoimmun. 20:2003;15-25
26. Brocker T. The role of dendritic cells in T cell selection and survival. J. Leukoc. Biol. 66:1999;331-335
27. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1994;1317-1330
28. Casciola-Rosen L., Andrade F., Ulanet D., Wong W.B., Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status. implications for initiation of autoimmunity J. Exp. Med. 190:1999;815-826
29. Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261
30. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184:1996;695-706
31. Caux C., Massacrier C., Vanbervliet B., Dubois B., Durand I., Cella M., Lanzavecchia A., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha. II. Functional analysis Blood. 90:1997;1458-1470
32. Cederblad B., Blomberg S., Vallin H., Perers A., Alm G.V., Ronnblom L. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J. Autoimmun. 11:1998;465-470
33. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce high levels of type I IFN. Nat. Med. 5:1999;919-923
34. Chabot S., Williams G., Yong V.W. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b. J. Clin. Invest. 100:1997;604-612
35. Chomarat P., Banchereau J., Davoust J., Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1:2000;510-514
36. Chomarat P., Dantin C., Bennett L., Banchereau J., Palucka A.K. TNF skews monocyte differentiation from macrophages to dendritic cells. J. Immunol. 171:2003;2262-2269
37. Cobbold S., Waldmann H. Infectious tolerance. Curr. Opin. Immunol. 10:1998;518-524
38. Davas E.M., Tsirogianni A., Kappou I., Karamitsos D., Economidou I., Dantis P.C. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin. Rheumatol. 18:1999;17-22
39. Desai-Mehta A., Lu L., Ramsey-Goldman R., Datta S.K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:1996;2063-2073
40. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis E.S.C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303:2004;1529-1531
41. Dubois B., Vanbervliet B., Fayette J., Massacrier C., Van Kooten C., Briere F., Banchereau J., Caux C. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185:1997;941-951
42. Dubois B., Massacrier C., Vanbervliet B., Fayette J., Briere F., Banchereau J., Caux C. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J. Immunol. 161:1998;2223-2231
43. Ehlers S. Role of tumour necrosis factor (TNF) in host defence against tuberculosis. implications for immunotherapies targeting TNF Ann. Rheum. Dis. 62:2003;ii37-ii42
44. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:1992;2207-2216
45. Farkas L., Beiske K., Lund-Johansen F., Brandtzaeg P., Jahnsen F.L. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159:2001;237-243
46. Fayette J., Dubois B., Vandenabeele S., Bridon J.M., Vanbervliet B., Durand I., Banchereau J., Caux C., Briere F. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J. Exp. Med. 185:1997;1909-1918
47. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53
48. Feldmann M., Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis. what have we learned? Annu. Rev. Immunol. 19:2001;163-196
49. Finkelman F.D., Lees A., Birnbaum R., Gause W.C., Morris S.C. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1996;1406-1414
50. Fujimoto Y., Tu L., Miller A.S., Bock C., Fujimoto M., Doyle C., Steeber D.A., Tedder T.F. CD83 expression influences CD4+ T cell development in the thymus. Cell. 108:2002;755-767
51. Galibert L., Burdin N., de Saint-Vis B., Garrone P., Van Kooten C., Banchereau J., Rousset F. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 183:1996;77-85
52. Gattorno M., Picco P., Barbano G., Stalla F., Sormani M.P., Buoncompagni A., Gusmano R., Borrone C., Pistoia V. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schonlein purpura and pediatric systemic lupus erythematosus. pathogenetic implications J. Rheumatol. 25:1998;361-365
53. Gill M.A., Blanco P., Arce E., Pascual V., Banchereau J., Palucka A.K. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum. Immunol. 63:2002;1172-1180
54. Gomez-Reino J.J., Carmona L., Valverde V.R., Mola E.M., Montero M.D. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk. a multicenter active-surveillance report Arthritis Rheum. 48:2003;2122-2127
55. Gottlieb A.B. Infliximab for psoriasis. J. Am. Acad. Dermatol. 49:2003;S112-S117
56. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., Xu W., Parrish-Novak J., Foster D., Lofton-Day C., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404:2000;995-999
57. Hanada T., Yoshida H., Kato S., Tanaka K., Masutani K., Tsukada J., Nomura Y., Mimata H., Kubo M., Yoshimura A. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity. 19:2003;437-450
58. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:2001;47-64
59. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303:2004;1526-1529
60. Hofman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170:1989;607-612
61. Hooks J.J., Moutsopoulos H.M., Geis S.A., Stahl N.I., Decker J.L., Notkins A.L. Immune interferon in the circulation of patients with autoimmune disease. N. Engl. J. Med. 301:1979;5-8
62. Huang F.P., Platt N., Wykes M., Major J.R., Powell T.J., Jenkins C.D., MacPherson G.G. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191:2000;435-444
63. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702
64. Jacob C.O., McDevitt H.O. Tumour necrosis factor-alpha in murine autoimmune "lupus" nephritis. Nature. 331:1988;356-358
65. Jacob C.O., Fronek Z., Lewis G.D., Koo M., Hansen J.A., McDevitt H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha. relevance to genetic predisposition to systemic lupus erythematosus Proc. Natl. Acad. Sci. USA. 87:1990;1233-1237
66. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 19:2003;225-234
67. Jung S., Unutmaz D., Wong P., Sano G., De los Santos K., Sparwasser T., Wu S., Vuthoori S., Ko K., Zavala F., et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity. 17:2002;211-220
68. Kadowaki N., Antonenko S., Lau J.Y., Liu Y.J. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192:2000;219-226
69. Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells. the concept of a third signal Immunol. Today. 20:1999;561-567
70. Kaplan M.J., Lu Q., Wu A., Attwood J., Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172:2004;3652-3661
71. Kato K., Santana-Sahagun E., Rassenti L.Z., Weisman M.H., Tamura N., Kobayashi S., Hashimoto H., Kipps T.J. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J. Clin. Invest. 104:1999;947-955
72. Katze M.G., He Y., Gale M. Viruses and interferon. a fight for supremacy Nat. Rev. Immunol. 2:2002;675-687
73. Kono D.H., Baccala R., Theofilopoulos A.N. Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor. Autoimmunity. 36:2003;503-510
74. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2001;2154-2163
75. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell. 106:2001;263-266
76. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:2002;603-607
77. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., Tough D.F. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 14:2001;461-470
78. Leonardi C.L., Powers J.L., Matheson R.T., Goffe B.S., Zitnik R., Wang A., Gottlieb A.B. Etanercept as monotherapy in patients with psoriasis. N. Engl. J. Med. 349:2003;2014-2022
79. Lin Q., Dong C., Cooper M.D. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187:1998;79-87
80. Lipsky P.E. Systemic lupus erythematosus. an autoimmune disease of B cell hyperactivity Nat. Immunol. 2:2001;764-766
81. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3:2002;822-829
82. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196:2002;1091-1097
83. Luft T., Pang K.C., Thomas E., Hertzog P., Hart D.N., Trapani J., Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1998;1947-1953
84. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1999;1697-1710
85. MacLennan I., Vinuesa C. Dendritic cells, BAFF, and APRIL. Innate players in adaptive antibody responses. Immunity. 17:2002;235-238
86. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science. 303:2004;1662-1665
87. Marrack P., Kappler J. Positive selection of thymocytes bearing alpha beta T cell receptors. Curr. Opin. Immunol. 9:1997;250-255
88. Marrack P., Kappler J., Kotzin B.L. Autoimmune disease. why and where it occurs Nat. Med. 7:2001;899-905
89. Medzhitov R., Janeway C.A. Jr. Innate immunity. the virtues of a nonclonal system of recognition Cell. 91:1997;295-298
90. Mohamadzadeh M., Berard F., Essert G., Chalouni C., Pulendran B., Davoust J., Bridges G., Palucka A.K., Banchereau J. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 194:2001;1013-1020
91. Mohty M., Vialle-Castellano A., Nunes J.A., Isnardon D., Olive D., Gaugler B. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J. Immunol. 171:2003;3385-3393
92. Moser M. Dendritic cells in immunity and tolerance - do they display opposite functions? Immunity. 19:2003;5-8
93. Mosmann T.R., Coffman R.L. TH1 and TH2 cells. different patterns of lymphokine secretion lead to different functional properties Annu. Rev. Immunol. 7:1989;145-173
94. Odendahl M., Jacobi A., Hansen A., Feist E., Hiepe F., Burmester G.R., Lipsky P.E., Radbruch A., Dorner T. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 165:2000;5970-5979
95. Palucka K., Banchereau J. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr. Opin. Immunol. 14:2002;420-431
96. Paquette R.L., Hsu N.C., Kiertscher S.M., Park A.N., Tran L., Roth M.D., Glaspy J.A. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukoc. Biol. 64:1998;358-367
97. Peters J.H., Xu H., Ruppert J., Ostermeier D., Friedrichs D., Gieseler R.K. Signals required for differentiating dendritic cells from human monocytes in vitro. Adv. Exp. Med. Biol. 329:1993;275-280
98. Preble O.T., Black R.J., Friedman R.M., Klippel J.H., Vilcek J. Systemic lupus erythematosus. presence in human serum of an unusual acid-labile leukocyte interferon Science. 216:1982;429-431
99. Pugh C.W., MacPherson G.G. Non-lymphoid cells from rat intestinal lymph. Adv. Exp. Med. Biol. 149:1982;781-789
100. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity. 11:1999;753-761
101. Reimold A.M. TNFalpha as therapeutic target. new drugs, more applications Curr. Drug Targets Inflamm. Allergy. 1:2002;377-392
102. Romagnani S. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:1995;121-129
103. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:1994;83-93
104. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., Levings M.K. Type 1 T regulatory cells. Immunol. Rev. 182:2001;68-79
105. Ronnblom L.E., Alm G.V., Oberg K.E. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann. Intern. Med. 115:1991;178-183
106. Rothuizen L.E., Buclin T., Spertini F., Trinchard I., Munafo A., Buchwalder P.A., Ythier A., Biollaz J. Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers. J. Neuroimmunol. 99:1999;131-141
107. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., Kuniyasu Y., Nomura T., Toda M., Takahashi T. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells. their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol. Rev. 182:2001;18-32
108. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1994;1109-1118
109. Santiago-Raber M.L., Baccala R., Haraldsson K.M., Choubey D., Stewart T.A., Kono D.H., Theofilopoulos A.N. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J. Exp. Med. 197:2003;777-788
110. Santini S.M., Lapenta C., Logozzi M., Parlato S., Spada M., Di Pucchio T., Belardelli F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:2000;1777-1788
111. Scapini P., Nardelli B., Nadali G., Calzetti F., Pizzolo G., Montecucco C., Cassatella M.A. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197:2003;297-302
112. Scheinecker C., McHugh R., Shevach E.M., Germain R.N. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:2002;1079-1090
113. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189:1999;1747-1756
114. Seifert U., Maranon C., Shmueli A., Desoutter J.F., Wesoloski L., Janek K., Henklein P., Diescher S., Andrieu M., de la Salle H., et al. An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat. Immunol. 4:2003;375-379
115. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954
116. Shevach E.M., McHugh R.S., Thornton A.M., Piccirillo C., Natarajan K., Margulies D.H. Control of autoimmunity by regulatory T cells. Adv. Exp. Med. Biol. 490:2001;21-32
117. Shlomchik M.J., Craft J.E., Mamula M.J. From T to B and back again. positive feedback in systemic autoimmune disease Nat. Rev. Immunol. 1:2001;147-153
118. Shodell M., Shah K., Siegal F.P. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus. 12:2003;222-230
119. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:2002;151-161
120. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837
121. Sobel E.S., Satoh M., Chen Y., Wakeland E.K., Morel L. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells. J. Immunol. 169:2002;2694-2700
122. Sprent J., Kishimoto H. The thymus and negative selection. Immunol. Rev. 185:2002;126-135
123. Starr T.K., Jameson S.C., Hogquist K.A. Positive and negative selection of T cells. Annu. Rev. Immunol. 21:2003;139-176
124. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296
125. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:2003;685-711
126. Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R., Issazadeh-Navikas S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170:2003;4776-4784
127. Tsokos G.C., Nambiar M.P., Tenbrock K., Juang Y.T. Rewiring the T-cell. signaling defects and novel prospects for the treatment of SLE Trends Immunol. 24:2003;259-263
128. Turley S.J. Dendritic cells. inciting and inhibiting autoimmunity Curr. Opin. Immunol. 14:2002;765-770
129. Vakkalanka R.K., Woo C., Kirou K.A., Koshy M., Berger D., Crow M.K. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum. 42:1999;871-881
130. Vallin H., Blomberg S., Alm G.V., Cederblad B., Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin. Exp. Immunol. 115:1999;196-202
131. Vermaelen K.Y., Carro-Muino I., Lambrecht B.N., Pauwels R.A. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:2001;51-60
132. Vieira P.L., de Jong E.C., Wierenga E.A., Kapsenberg M.L., Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164:2000;4507-4512
133. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity. 19:2003;837-847
134. von Wussow P., Jakschies D., Hartung K., Deicher H. Presence of interferon and anti-interferon in patients with systemic lupus erythematosus. Rheumatol. Int. 8:1988;225-230
135. Wakeland E.K., Liu K., Graham R.R., Behrens T.W. Delineating the genetic basis of systemic lupus erythematosus. Immunity. 15:2001;397-408
136. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science. 301:2003;1374-1377
137. Wykes M., Pombo A., Jenkins C., MacPherson G.G. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161:1998;1313-1319
138. Yu M., Nishiyama A., Trapp B.D., Tuohy V.K. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J. Neuroimmunol. 64:1996;91-100